Acadia Pharmaceuticals (ACAD) Beats Q2 Earnings and Revenue Estimates
ACADACADIA Pharmaceuticals(ACAD) ZACKS·2024-08-07 06:47

Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of 0.20pershare,beatingtheZacksConsensusEstimateof0.20 per share, beating the Zacks Consensus Estimate of 0.16 per share. This compares to earnings of 0.01pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof250.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this drugmaker would post earnings of 0.04 per share when it actually produced earnings of $0.10, delivering a surprise of 150%.Over the last four quarters, the comp ...